KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $392.1 million.

  • Biolife Solutions' Liabilities and Shareholders Equity rose 273.26% to $392.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 19.13%. This contributed to the annual value of $399.5 million for FY2024, which is 320.49% down from last year.
  • Latest data reveals that Biolife Solutions reported Liabilities and Shareholders Equity of $392.1 million as of Q3 2025, which was up 273.26% from $387.2 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Liabilities and Shareholders Equity peaked at $559.4 million during Q3 2021, and registered a low of $240.0 million during Q1 2021.
  • Over the past 5 years, Biolife Solutions' median Liabilities and Shareholders Equity value was $412.7 million (recorded in 2023), while the average stood at $434.9 million.
  • As far as peak fluctuations go, Biolife Solutions' Liabilities and Shareholders Equity surged by 35711.06% in 2021, and later crashed by 1877.32% in 2022.
  • Over the past 5 years, Biolife Solutions' Liabilities and Shareholders Equity (Quarter) stood at $554.3 million in 2021, then dropped by 18.77% to $450.2 million in 2022, then decreased by 8.33% to $412.7 million in 2023, then decreased by 3.2% to $399.5 million in 2024, then decreased by 1.85% to $392.1 million in 2025.
  • Its Liabilities and Shareholders Equity was $392.1 million in Q3 2025, compared to $387.2 million in Q2 2025 and $395.1 million in Q1 2025.